Use of AB-103 (a “dual antagonist”) in the treatment of bronchogenic carcinoma
- 1 July 1961
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Nitrogen Mustard in the Palliation of Lung CancerBMJ, 1960
- Brief Note: A Technic of Bone Marrow Transplantation in ManBlood, 1960
- ‘Dual Antagonists’; Alkyl N-(bis-(ethylenimido)phosphoro)-carbamates; a New Series of Anti-Tumour AgentsNature, 1959
- SUMMARY OF RESULTS OBTAINED WITH NITROGEN MUSTARD IN THE TREATMENT OF NEOPLASTIC DISEASEAnnals of the New York Academy of Sciences, 1958
- DIRECT INSTILLATION OF NITROGEN MUSTARD IN THE MANAGEMENT OF MALIGNANT EFFUSIONSAnnals of the New York Academy of Sciences, 1958
- FUTURE EXPERIMENTAL APPROACHESAnnals of the New York Academy of Sciences, 1958
- NECESSARY CRITERIA FOR THE COMPARATIVE EVALUATION OF ALKYLATING AGENTS IN CLINICAL CANCER CHEMOTHERAPYAnnals of the New York Academy of Sciences, 1958
- THE STATUS OF ALKYLATING AGENTS IN CLINICAL CANCER CHEMOTHERAPYAnnals of the New York Academy of Sciences, 1958
- Nitrogen Mustard as an Adjunct to Radiation in the Management of Bronchogenic CancerRadiology, 1951
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948